FDA approves Plavix generics

FDA approved generic versions of Plavix clopidogrel late Thursday as the cardiovascular drug from Sanofi (Euronext:SAN; NYSE:SNY) and Bristol-Myers Squibb Co. (NYSE:BMY) lost market exclusivity. The adenosine diphosphate (ADP) receptor (P2Y12) antagonist had U.S. sales of EUR 4.8 billion ($6.2 billion) in 2011. ...